Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod-Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC).
Vaccines（2023）
摘要
The antibody and T-cell responses support SARS-CoV-2 (booster) vaccines in siponimod-treated patients.
更多查看译文
关键词
COVID-19 vaccination,T-cell response,disease-modifying therapy,neutralizing antibodies,secondary progressive multiple sclerosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要